Form 4: Korro Bio Director Ali Behbahani Acquires Stock Options

Director Ali Behbahani reports the acquisition of stock options in Korro Bio, Inc.

Summary

• On June 11, 2024, Ali Behbahani, a director of Korro Bio, Inc. (KRRO), acquired 5,190 stock options.
• The exercise price of these options is $42.19.
• The options vest on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting of stockholders, contingent upon continued service as a non-employee director.
• Following the transaction, Behbahani directly owns 5,190 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock option acquisition by a director, which doesn't inherently indicate positive or negative sentiment but suggests alignment of interests.

Positives

• The acquisition of stock options by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities, providing investors with insights into the actions of company insiders.

Stakeholder Impact

• The acquisition of stock options by a director may signal to shareholders that the director is incentivized to improve the company's performance.

Key Dates